92 related articles for article (PubMed ID: 35777616)
1. Bioequivalence of a hybrid pegylated liposomal doxorubicin hydrochloride injection and Caelyx®: A single-dose, randomized, multicenter, open-label, two-period crossover study in patients with advanced ovarian cancer.
S PS; Nagarkar RV; Puligundla KC; N LK; Boya RR; Patel AB; Goyal L; Thoke A; Patel JG; Mehta AO; Patel GN; Khan MA; Ahmad I
Eur J Pharm Sci; 2022 Sep; 176():106248. PubMed ID: 35777616
[TBL] [Abstract][Full Text] [Related]
2. A multicenter randomized trials to compare the bioequivalence and safety of a generic doxorubicin hydrochloride liposome injection with Caelyx
Li Y; Qi L; Wang Y; Li Y; Lei C; Zhang Y; Cheng X; Liu J; Bai H; Zhao X; Lv S; Xiong B; Liu J; Shi Y; Zhou H; Li H; Liu L; Jiang H; Ouyang W; Li X; Li Y; Wang X
Front Oncol; 2022; 12():1070001. PubMed ID: 36605440
[TBL] [Abstract][Full Text] [Related]
3. Two multicenter Phase I randomized trials to compare the bioequivalence and safety of a generic doxorubicin hydrochloride liposome injection with Doxil
Bhowmik S; Bhowmick S; Maiti K; Chakra A; Shahi P; Jain D; Rajamannar T
Cancer Chemother Pharmacol; 2018 Sep; 82(3):521-532. PubMed ID: 29995186
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetic and Safety Comparison of Two Capecitabine Tablets in Patients with Colorectal or Breast Cancer Under Fed Conditions: A Multicenter, Randomized, Open-Label, Three-Period, and Reference-Replicated Crossover Study.
Wang CJ; Li T; Lin PP; Tao Y; Jiang X; Li X; Wen Q; Cao Y
Adv Ther; 2021 Sep; 38(9):4798-4814. PubMed ID: 34347254
[TBL] [Abstract][Full Text] [Related]
5. Bioequivalence Study of Palbociclib Capsules in Healthy Chinese Subjects Under Fasting and Fed Conditions.
Chu NN; Zhang L; Wang J; Gu X; Ding Y; Huang K; Que LL; He Q
Clin Drug Investig; 2022 Jan; 42(1):53-63. PubMed ID: 34837169
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics, efficacy and toxicity of different pegylated liposomal doxorubicin formulations in preclinical models: is a conventional bioequivalence approach sufficient to ensure therapeutic equivalence of pegylated liposomal doxorubicin products?
Mamidi RN; Weng S; Stellar S; Wang C; Yu N; Huang T; Tonelli AP; Kelley MF; Angiuoli A; Fung MC
Cancer Chemother Pharmacol; 2010 Nov; 66(6):1173-84. PubMed ID: 20661737
[TBL] [Abstract][Full Text] [Related]
7. Lipodox® (generic doxorubicin hydrochloride liposome injection): in vivo efficacy and bioequivalence versus Caelyx® (doxorubicin hydrochloride liposome injection) in human mammary carcinoma (MX-1) xenograft and syngeneic fibrosarcoma (WEHI 164) mouse models.
Burade V; Bhowmick S; Maiti K; Zalawadia R; Ruan H; Thennati R
BMC Cancer; 2017 Jun; 17(1):405. PubMed ID: 28587612
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics and bioequivalence of two oral formulations of canagliflozin after single-dose administration in healthy Chinese subjects
.
Hu W; Yang Y; Zhang Q; Yang Y; Zhou R; Lu C; Liu Z
Int J Clin Pharmacol Ther; 2020 Jan; 58(1):57-65. PubMed ID: 31347489
[TBL] [Abstract][Full Text] [Related]
9. Bioequivalence of fixed dose combination of atorvastatin 10 mg and aspirin 150 mg capsules: a randomized, open-label, single-dose, two-way crossover study in healthy human subjects.
Tippabhotla SK; Betha MR; Gadiko C; Battula R; Nakkawar M; Cheerla R; Khan SM; Yergude S; Thota S; Vobalaboina V
Drug Res (Stuttg); 2013 May; 63(5):250-7. PubMed ID: 23526241
[TBL] [Abstract][Full Text] [Related]
10. Bioequivalence study of two perindopril tert-butylamine tablet formulations in healthy Chinese subjects under fasting and fed conditions: A randomized, open-label, single-dose, crossover trial.
Li Q; Hao Z; Yu Y; Tang Y
Biomed Pharmacother; 2021 Mar; 135():111221. PubMed ID: 33433351
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics and bioequivalence study of two ciprofloxacin hydrochloride tablets in healthy Chinese subjects under fasting and fed conditions: A randomized, open-label, two-formulation, two-sequence, two-period, single-dose crossover study.
Qin F; Wang GM; Huang JY; Wu JR; Song WJ; Deng J; Xiao Y; Wang JS; Zhu KW
Int J Clin Pharmacol Ther; 2021 Dec; 59(12):804-816. PubMed ID: 34503644
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics and bioequivalence study of irbesartan tablets after a single oral dose of 300 mg in healthy Thai volunteers.
Wittayalertpanya S; Chariyavilaskul P; Prompila N; Sayankuldilok N; Eiamart W
Int J Clin Pharmacol Ther; 2014 May; 52(5):431-6. PubMed ID: 24725445
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetic and bioequivalence study of new S-1 capsule in Chinese cancer patients.
Chen Y; Jiang Y; Qu J; Wang Q; Bai Y; Shi J; Shi Y; Chen X; Yang N; Heng J; Li K
Eur J Pharm Sci; 2020 Aug; 151():105384. PubMed ID: 32470574
[TBL] [Abstract][Full Text] [Related]
14. A randomized, open-label, two-period crossover bridging study on fuzuloparib capsules of different specifications in healthy Chinese volunteers.
Jiang X; Tao Y; Liu Y; Shi P; Li T; Sun F; Cao Y; Wang C
Br J Clin Pharmacol; 2022 Mar; 88(3):1087-1093. PubMed ID: 34378245
[TBL] [Abstract][Full Text] [Related]
15. Metronidazole immediate release formulations: a fasting randomized open-label crossover bioequivalence study in healthy volunteers.
de Freitas Silva M; Schramm SG; Kano EK; Koono EE; Manfio JL; Porta V; dos Reis Serra CH
Arzneimittelforschung; 2012 Oct; 62(10):490-5. PubMed ID: 22918856
[TBL] [Abstract][Full Text] [Related]
16. Bioequivalence and Pharmacokinetic Profiles of Agomelatine 25-mg Tablets in Healthy Chinese Subjects: A Four-Way Replicate Crossover Study Demonstrating High Intra- and Inter-Individual Variations.
Li C; Xu J; Zheng Y; Chen G; Wang J; Ma L; Qiao Y; Niu J; Wu M; Zhang H; Li X; Chen H; Zhu X; Liu C; Ding Y
Chem Pharm Bull (Tokyo); 2017 Jun; 65(6):524-529. PubMed ID: 28392509
[TBL] [Abstract][Full Text] [Related]
17. Single dose bioequivalence study of two brands of olanzapine 10 mg tablets in Iranian healthy volunteers.
Zakeri-Milani P; Islambulchilar Z; Ghanbarzadeh S; Valizadeh H
Drug Res (Stuttg); 2013 Jul; 63(7):346-50. PubMed ID: 23605469
[TBL] [Abstract][Full Text] [Related]
18. Assessment of the bioequivalence of two formulations of clarithromycin extended-release 500-mg tablets under fasting and fed conditions: a single-dose, randomized, open-label, two-period, two-way crossover study in healthy Jordanian male volunteers.
Alkhalidi BA; Tamimi JJ; Salem II; Ibrahim H; Sallam AA
Clin Ther; 2008 Oct; 30(10):1831-43. PubMed ID: 19014838
[TBL] [Abstract][Full Text] [Related]
19. Bioequivalence study of 20-mg and 100-mg temozolomide capsules (TOZ309 and Temodal
Hu C; Lin Q; Liu C; Liu J; Chen X; Li X; Zhao G; Zhang L
Cancer Chemother Pharmacol; 2020 Dec; 86(6):793-801. PubMed ID: 33089408
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and toxicity profile of pegylated liposomal doxorubicin in patients with advanced ovarian cancer.
Mayer C; Brucker J; Schuetz F; Domschke C; Bechstein S; Heil J; Golatta M; Wallwiener M; Sohn C; Schneeweiss A; Rom J
Arch Gynecol Obstet; 2016 Jul; 294(1):123-9. PubMed ID: 26498757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]